ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

133
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
28 Apr 2020 16:36

More Covering on Consumer Staples and Discretionary

The short notional in the market for the data released 28 April is US$33.44bn (down by US$62mm excluding FX movements and ETFs) with the largest...

Logo
304 Views
Share
02 Apr 2020 18:57

J&J’s Purchase of Takeda’s Surgical Patch Subject to EU Investigation; Expect a Deal Anyways

In May 2019, Japan’s biggest drugmaker, Takeda announced the sale of its surgical patch product, TachoSil to Johnson & Johnson’s subsidiary...

Share
bullishAstellas Pharma
30 Dec 2019 14:01

Japan’s Astellas Pharma Buys US-Based Xyphos Biosciences Inc.

It was reported by Reuters and several other media that the Japan-based Astellas Pharma has bought the US-based Xyphos Bioscience Inc. in a deal...

Share
bullishAstellas Pharma
04 Dec 2019 17:58

Japan’s Astellas Pharma to Buy Audentes Therapeutics to Expand into Gene Therapy Market

It was reported by Reuters and several other media that the Japan-based Astellas Pharma has agreed to buy the US-based Audentes Therapeutics for...

Share
bullishAstellas Pharma
31 Oct 2019 12:02

Astellas Pharma - Another Buyback

An hour ago, Astellas Pharma (4503 JP) announced a buyback for up to 32mm shares (around 1.7% of shares outstanding excluding Treasury shares) and...

Logo
365 Views
Share
x